Table 4.
Comparison of clinical data between the NMDARE_SD and NMDARE_LD.
| Characteristics | NMDARE_LD (n = 18) | NMDARE_SD (n = 22) | P value |
|---|---|---|---|
| Gender (M/F) | 10/8 | 6/16 | 0.07* |
| Age (years) | 28.11 ± 10.36 | 26.68 ± 8.55 | 0.64 |
| Education (years) | 13.17 ± 4.05 | 13.55 ± 3.38 | 0.75 |
| Age of onset (years) | 25.50 ± 10.55 | 26.00 ± 8.47 | 0.87 |
| Disease duration (months) | 32.89 ± 10.41 | 8.64 ± 4.61 | – |
| MoCA scores | 25.28 ± 4.54 | 24.50 ± 5.34 | 0.63 |
| HAMD24 scores | 4.28 ± 3.75 | 5.59 ± 6.12 | 0.43 |
| HAMA | 2.56 ± 2.46 | 3.91 ± 3.48 | 0.17 |
| Executive control scores(ms) | 124.35 ± 71.91 | 122.82 ± 56.99 | 0.94 |
NMDARE_SD, Anti-NMDAR encephalitis with short disease duration (≤ 2 years since diagnosis); NMDARE_LD, Anti-NMDAR encephalitis with long disease duration (>2 years since diagnosis); M, male; F, female; MoCA, montreal cognitive assessment test; HAMD24, hamilton depression scale-24; HAMA, hamilton anxiety scale. p <0.05 was considered statistically significant. *χ2 test for sex (n). Independent t-test for the other data (means ± SD).